These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25186973)

  • 1. Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease.
    Kawai T; Watanabe N; Yokoyama M; Nakazawa Y; Goto F; Uchiyama T; Higuchi M; Maekawa T; Tamura E; Nagasaka S; Hojo M; Onodera M
    J Clin Immunol; 2014 Nov; 34(8):933-40. PubMed ID: 25186973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
    Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
    Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.
    Esenboga S; Emiralioglu N; Cagdas D; Erman B; De Boer M; Oguz B; Kiper N; Tezcan İ
    J Clin Immunol; 2017 Apr; 37(3):269-272. PubMed ID: 28224353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Identification of Lung Fungal Infections in Chronic Granulomatous Disease (CGD) Using Multidetector Computer Tomography.
    Bondioni MP; Lougaris V; Di Gaetano G; Lorenzini T; Soresina A; Laffranchi F; Gatta D; Plebani A
    J Clin Immunol; 2017 Jan; 37(1):36-41. PubMed ID: 27766541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease.
    Magnani A; Brosselin P; Beauté J; de Vergnes N; Mouy R; Debré M; Suarez F; Hermine O; Lortholary O; Blanche S; Fischer A; Mahlaoui N
    J Allergy Clin Immunol; 2014 Sep; 134(3):655-662.e8. PubMed ID: 24985400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease.
    Kawai T; Watanabe N; Yokoyama M; Arai K; Oana S; Harayama S; Yasui K; Oh-Ishi T; Onodera M
    Clin Immunol; 2013 May; 147(2):122-8. PubMed ID: 23583898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.
    Kawase S; Hattori N; Ishikawa N; Horimasu Y; Fujitaka K; Furonaka O; Isobe T; Miyoshi S; Hamada H; Yamane T; Yokoyama A; Kohno N
    Respir Res; 2011 Jul; 12(1):97. PubMed ID: 21791074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
    Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
    Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
    Miyazaki K; Kurishima K; Kagohashi K; Kawaguchi M; Ishikawa H; Satoh H; Hizawa N
    J Clin Lab Anal; 2010; 24(5):295-9. PubMed ID: 20872562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
    Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
    Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
    Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
    Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy.
    Khangura SK; Kamal N; Ho N; Quezado M; Zhao X; Marciano B; Simpson J; Zerbe C; Uzel G; Yao MD; DeRavin SS; Hadigan C; Kuhns DB; Gallin JI; Malech HL; Holland SM; Heller T
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):395-402.e5. PubMed ID: 26545803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary manifestations of chronic granulomatous disease.
    Mahdaviani SA; Mohajerani SA; Rezaei N; Casanova JL; Mansouri SD; Velayati AA
    Expert Rev Clin Immunol; 2013 Feb; 9(2):153-60. PubMed ID: 23390946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
    Ishikawa N; Hattori N; Yokoyama A; Kohno N
    Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.
    Gabrion A; Hmitou I; Moshous D; Neven B; Lefèvre-Utile A; Diana JS; Suarez F; Picard C; Blanche S; Fischer A; Cavazzana M; Touzot F
    J Allergy Clin Immunol; 2017 May; 139(5):1641-1649.e6. PubMed ID: 27702670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.